# The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

> **NCT01159405** · PHASE1 · UNKNOWN · sponsor: **SeeCure LLC** · enrollment: 9 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Radiolabeled (99mTc) GP (Glycopeptide)

## Key facts

- **NCT ID:** NCT01159405
- **Lead sponsor:** SeeCure LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2014-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159405, "The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01159405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*